Cook Andrew D, Vlahos Ross, Massa Christine M, Braine Emma L, Lenzo Jason C, Turner Amanda L, Way Kerrie J, Hamilton John A
Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Royal Parade, Parkville, 3010, Victoria, Australia.
Thromb Haemost. 2006 Apr;95(4):659-67.
There are two plasminogen activators (PAs), urokinase type-PA (u-PA) and tissue type-PA (t-PA). While u-PA is considered to be involved in cellular migration and tissue remodeling and t-PA in fibrinolysis, this distinction is not always clear-cut. With the use of u-PA and t-PA gene deficient mice (u-PA-/- and t-PA-/- mice, respectively) we have assessed the role of each PA in acute peritonitis. The cellular infiltrate in both thioglycolate- and antigen-induced peritoneal exudates was unaffected in u-PA-/- mice; in contrast, in t-PA-/- mice, the macrophage numbers, particularly of the Mac-1(hi) population, in the peritoneal cavity by day 4 were significantly reduced compared to wild-type mice. However, examination of the peritoneal wall revealed in fact increased numbers of macrophages adhering on/in the cavity lining at all time points studied; in addition, increased fibrin(ogen) staining was observed for these mice. The reduced macrophage numbers in the peritoneal cavities of t-PA-/- mice could be increased by administration of plasmin or t-PA prior to harvesting the thioglycolate-elicited exudates. These results suggest that t-PA and not u-PA is the PA controlling fibrinolysis in murine peritonitis. In its absence macrophages adhere to the accumulated fibrin(ogen) on/in the cavity wall lining, most likely via Mac-1 binding, thus affecting migration into and/or out of the peritoneal cavity. They also highlight the need to examine both the peritoneal cavity and wall in order to monitor accurately the extent of a peritoneal inflammatory reaction. Peritoneal inflammation in t-PA-/- mice represents a useful model to study the progression of intra-abdominal adhesions during surgery and clinical peritonitis.
有两种纤溶酶原激活剂(PAs),即尿激酶型纤溶酶原激活剂(u-PA)和组织型纤溶酶原激活剂(t-PA)。虽然u-PA被认为参与细胞迁移和组织重塑,而t-PA参与纤维蛋白溶解,但这种区分并不总是明确的。通过使用u-PA和t-PA基因缺陷小鼠(分别为u-PA-/-和t-PA-/-小鼠),我们评估了每种PA在急性腹膜炎中的作用。在u-PA-/-小鼠中,硫乙醇酸盐和抗原诱导的腹腔渗出液中的细胞浸润未受影响;相比之下,在t-PA-/-小鼠中,到第4天时,腹腔中巨噬细胞数量,特别是Mac-1(hi)群体的数量,与野生型小鼠相比显著减少。然而,对腹膜壁的检查实际上显示,在所有研究的时间点,附着在腹腔内衬上/内的巨噬细胞数量增加;此外,观察到这些小鼠的纤维蛋白(原)染色增加。在收集硫乙醇酸盐诱导的渗出液之前,给予纤溶酶或t-PA可增加t-PA-/-小鼠腹腔中减少的巨噬细胞数量。这些结果表明,在小鼠腹膜炎中控制纤维蛋白溶解的PA是t-PA而不是u-PA。在缺乏t-PA的情况下,巨噬细胞最有可能通过Mac-1结合附着在腹腔壁内衬上/内积累的纤维蛋白(原)上,从而影响进入和/或离开腹腔的迁移。它们还强调了需要同时检查腹腔和腹膜壁,以便准确监测腹膜炎症反应的程度。t-PA-/-小鼠的腹膜炎症代表了一个有用的模型,可用于研究手术期间腹腔内粘连的进展以及临床腹膜炎。